2024 ICD-10-CM Diagnosis Code T37.8X5D
Adverse effect of other specified systemic anti-infectives and antiparasitics, subsequent encounter
- ICD-10-CM Code:
- T37.8X5D
- ICD-10 Code for:
- Adverse effect of systemic anti-infect/parasit, subs
- Is Billable?
- Yes - Valid for Submission
- Chronic Condition Indicator: [1]
- Not chronic
- Code Navigator:
- Code Information
- Approximate Synonyms
- Clinical Classification
- Clinical Information
- Coding Guidelines
- Tabular List of Diseases and Injuries
- Code Edits
- Diagnostic Related Groups Mapping
- Present on Admission (POA)
- Convert to ICD-9 Code
- Table of Drugs and Chemicals
- Patient Education
- Other Codes Used Similar Conditions
- Code History
T37.8X5D is a billable diagnosis code used to specify a medical diagnosis of adverse effect of other specified systemic anti-infectives and antiparasitics, subsequent encounter. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024. The code is exempt from present on admission (POA) reporting for inpatient admissions to general acute care hospitals.
This code describes a circumstance which influences the patient's health status but not a current illness or injury. The code is unacceptable as a principal diagnosis.
T37.8X5D is a subsequent encounter code, includes a 7th character and should be used after the patient has completed active treatment for a condition like adverse effect of other specified systemic anti-infectives and antiparasitics. According to ICD-10-CM Guidelines a "subsequent encounter" occurs when the patient is receiving routine care for the condition during the healing or recovery phase of treatment. Subsequent diagnosis codes are appropriate during the recovery phase, no matter how many times the patient has seen the provider for this condition. If the provider needs to adjust the patient's care plan due to a setback or other complication, the encounter becomes active again.
Approximate Synonyms
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- 4-quinolones adverse reaction
- 4-quinolones adverse reaction
- Adverse reaction to bismuth and/or bismuth compound
- Adverse reaction to chiniofon
- Adverse reaction to dichloroacetamide
- Adverse reaction to diiodohydroxyquin
- Adverse reaction to hexamine
- Adverse reaction to oxyquinoline
- Adverse reaction to sulfamethoxazole and/or trimethoprim
- Amidine disinfectant adverse reaction
- Aminoquinoline antimalarial adverse reaction
- Aminoquinoline antimalarial adverse reaction
- Aminoquinoline antimalarial adverse reaction
- Aminoquinoline antimalarial adverse reaction
- Aminoquinoline antimalarial adverse reaction
- Bilateral retinopathy of eyes caused by hydroxychloroquine
- Bismuth chelate adverse reaction
- Cinoxacin adverse reaction
- Clioquinol adverse reaction
- Fluconazole adverse reaction
- Flucytosine adverse reaction
- Hexamine hippurate adverse reaction
- Hexetidine adverse reaction
- Hydrochloroquine retinopathy
- Hydrochloroquine retinopathy
- Hydrochloroquine retinopathy
- Hydrochloroquine retinopathy
- Hydroxychloroquine adverse reaction
- Hydroxychloroquine adverse reaction
- Hydroxychloroquine adverse reaction
- Hydroxychloroquine adverse reaction
- Hydroxychloroquine adverse reaction
- Imidazole antifungal adverse reaction
- Itraconazole adverse reaction
- Maculopapular eruption
- Maculopapular rash caused by fluoroquinolone
- Mandelic acid adverse reaction
- Metronidazole adverse reaction
- Nalidixic acid adverse reaction
- Nitrofurantoin adverse reaction
- Nitroimidazole adverse reaction
- Retinopathy of left eye caused by hydroxychloroquine
- Retinopathy of left eye caused by hydroxychloroquine
- Retinopathy of right eye caused by hydroxychloroquine
- Retinopathy of right eye caused by hydroxychloroquine
- Toxic encephalopathy due to hydroxyquinoline
- Triazole antifungals adverse reaction
- Triazole antifungals adverse reaction
- Trimethoprim adverse reaction
Clinical Classification
Clinical Category is Adverse effects of drugs and medicaments, subsequent encounter
- CCSR Category Code: INJ065
- Inpatient Default CCSR: X - Not applicable.
- Outpatient Default CCSR: Y - Yes, default outpatient assignment for principal diagnosis or first-listed diagnosis.
Clinical Information
Bithionol
halogenated anti-infective agent that is used against trematode and cestode infestations.Cinoxacin
synthetic antimicrobial related to oxolinic acid and nalidixic acid and used in urinary tract infections.Clioquinol
a potentially neurotoxic 8-hydroxyquinoline derivative long used as a topical anti-infective, intestinal antiamebic, and vaginal trichomonacide. the oral preparation has been shown to cause subacute myelo-optic neuropathy and has been banned worldwide.Fluconazole
triazole antifungal agent that is used to treat oropharyngeal candidiasis and cryptococcal meningitis in aids.Flucytosine
a fluorinated cytosine analog that is used as an antifungal agent.Furazolidone
a nitrofuran derivative with antiprotozoal and antibacterial activity. furazolidone acts by gradual inhibition of monoamine oxidase. (from martindale, the extra pharmacopoeia, 30th ed, p514)Hexetidine
a bactericidal and fungicidal antiseptic. it is used as a 0.1% mouthwash for local infections and oral hygiene. (from martindale, the extra pharmacopoeia, 30th ed, p797)Hydroxychloroquine
a chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. it inhibits plasmodial heme polymerase. (from gilman et al., goodman and gilman's the pharmacological basis of therapeutics, 9th ed, p970)Iodoquinol
one of the halogenated 8-quinolinols widely used as an intestinal antiseptic, especially as an antiamebic agent. it is also used topically in other infections and may cause cns and eye damage. it is known by very many similar trade names world-wide.Itraconazole
a triazole antifungal agent that inhibits cytochrome p-450-dependent enzymes required for ergosterol synthesis.Diatrizoate Meglumine
a versatile contrast medium used for diagnostic x-ray radiology.Iothalamate Meglumine
a radiopaque medium used for urography, angiography, venography, and myelography. it is highly viscous and binds to plasma proteins.Ioxaglic Acid
a low-osmolar, ionic contrast medium used in various radiographic procedures.Meglumine
1-deoxy-1-(methylamino)-d-glucitol. a derivative of sorbitol in which the hydroxyl group in position 1 is replaced by a methylamino group. often used in conjunction with iodinated organic compounds as contrast medium.Meglumine Antimoniate
antimony salt of meglumine that is used in the treatment of leishmaniasis.Metronidazole
a nitroimidazole used to treat amebiasis; vaginitis; trichomonas infections; giardiasis; anaerobic bacteria; and treponemal infections.Nalidixic Acid
a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum. it is an inhibitor of the a subunit of bacterial dna gyrase.Nifuratel
local antiprotozoal and antifungal agent that may also be given orally.Nitrofurantoin
a urinary anti-infective agent effective against most gram-positive and gram-negative organisms. although sulfonamides and antibiotics are usually the agents of choice for urinary tract infections, nitrofurantoin is widely used for prophylaxis and long-term suppression.Oxolinic Acid
synthetic antimicrobial related to nalidixic acid and used in urinary tract infections.Pefloxacin
a synthetic broad-spectrum fluoroquinolone antibacterial agent active against most gram-negative and gram-positive bacteria.Pipemidic Acid
antimicrobial against gram negative and some gram positive bacteria. it is protein bound and concentrated in bile and urine and used for gastrointestinal, biliary, and urinary infections.Piromidic Acid
antibacterial against mainly gram negative organisms. it is used for urinary tract and intestinal infections.Trimethoprim
a pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to pyrimethamine. it is potentiated by sulfonamides and the trimethoprim, sulfamethoxazole drug combination is the form most often used. it is sometimes used alone as an antimalarial. trimethoprim resistance has been reported.Trimethoprim Resistance
nonsusceptibility of bacteria to the action of trimethoprim.Trimethoprim, Sulfamethoxazole Drug Combination
a drug combination with broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms. it is effective in the treatment of many infections, including pneumocystis pneumonia in aids.
Coding Guidelines
When coding an adverse effect of a drug that has been correctly prescribed and properly administered, assign the appropriate code for the nature of the adverse effect followed by the appropriate code for the adverse effect of the drug.
The appropriate 7th character is to be added to each code from block Poisoning by, adverse effect of and underdosing of other systemic anti-infectives and antiparasitics (T37). Use the following options for the aplicable episode of care:
- A - initial encounter
- D - subsequent encounter
- S - sequela
Code Edits
The Medicare Code Editor (MCE) detects and reports errors in the coding of claims data. The following ICD-10-CM Code Edits are applicable to this code:
- Unacceptable principal diagnosis - There are selected codes that describe a circumstance which influences an individual's health status but not a current illness or injury, or codes that are not specific manifestations but may be due to an underlying cause. These codes are considered unacceptable as a principal diagnosis.
Present on Admission (POA)
T37.8X5D is exempt from POA reporting - The Present on Admission (POA) indicator is used for diagnosis codes included in claims involving inpatient admissions to general acute care hospitals. POA indicators must be reported to CMS on each claim to facilitate the grouping of diagnoses codes into the proper Diagnostic Related Groups (DRG). CMS publishes a listing of specific diagnosis codes that are exempt from the POA reporting requirement. Review other POA exempt codes here.
CMS POA Indicator Options and Definitions
POA Indicator | Reason for Code | CMS will pay the CC/MCC DRG? |
---|---|---|
Y | Diagnosis was present at time of inpatient admission. | YES |
N | Diagnosis was not present at time of inpatient admission. | NO |
U | Documentation insufficient to determine if the condition was present at the time of inpatient admission. | NO |
W | Clinically undetermined - unable to clinically determine whether the condition was present at the time of inpatient admission. | YES |
1 | Unreported/Not used - Exempt from POA reporting. | NO |
Convert T37.8X5D to ICD-9-CM
- ICD-9-CM Code: V58.89 - Other specfied aftercare
Approximate Flag - The approximate mapping means there is not an exact match between the ICD-10 and ICD-9 codes and the mapped code is not a precise representation of the original code.
Table of Drugs and Chemicals
The parent code T37.8X5 of the current diagnosis code is referenced in the Table of Drugs and Chemicals, this table contains a classification of drugs, industrial solvents, corrosive gases, noxious plants, pesticides, and other toxic agents.
According to ICD-10-CM coding guidelines it is advised to do not code directly from the Table of Drugs and Chemicals, instead always refer back to the Tabular List when doing the initial coding. Each substance in the table is assigned a code according to the poisoning classification and external causes of adverse effects. It is important to use as many codes as necessary to specify all reported drugs, medicinal or chemical substances. If the same diagnosis code describes the causative agent for more than one adverse reaction, poisoning, toxic effect or underdosing, utilize the code only once.
Patient Education
Drug Reactions
Most of the time, medicines make our lives better. They reduce aches and pains, fight infections, and control problems such as high blood pressure or diabetes. But medicines can also cause unwanted reactions, such as drug interactions, side effects, and allergies.
What is a drug interaction?
A drug interaction is a change in the way a drug acts in the body when taken with certain other drugs, foods, or supplements or when taken while you have certain medical conditions. Examples include:
- Two drugs, such as aspirin and blood thinners
- Drugs and food, such as statins and grapefruit
- Drugs and supplements, such as gingko and blood thinners
- Drugs and medical conditions, such as aspirin and peptic ulcers
Interactions could cause a drug to be more or less effective, cause side effects, or change the way one or both drugs work.
What are side effects?
Side effects are unwanted, usually unpleasant, effects caused by medicines. Most are mild, such as a stomachache, dry mouth, or drowsiness, and go away after you stop taking the medicine. Others can be more serious. Sometimes a drug can interact with a disease that you have and cause a side effect. For example, if you have a heart condition, certain decongestants can cause you to have a rapid heartbeat.
What are drug allergies?
Drug allergies are another type of reaction. They can range from mild to life-threatening. Skin reactions, such as hives and rashes, are the most common type. Anaphylaxis, a serious allergic reaction, is less common.
How can I stay safe when taking medicines?
When you start a new prescription or over-the-counter medicine, make sure you understand how to take it correctly. Know which other medicines, foods, and supplements you need to avoid. Always talk to your health care provider or pharmacist if you have questions about your medicines.
[Learn More in MedlinePlus]
Code History
- FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
- FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
- FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.
Footnotes
[1] Not chronic - A diagnosis code that does not fit the criteria for chronic condition (duration, ongoing medical treatment, and limitations) is considered not chronic. Some codes designated as not chronic are acute conditions. Other diagnosis codes that indicate a possible chronic condition, but for which the duration of the illness is not specified in the code description (i.e., we do not know the condition has lasted 12 months or longer) also are considered not chronic.